EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda Submitted by admin on Sat, 07/22/2017 - 12:23 Read more about EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda Source RAPS.org Headline EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda News Tags EMA Europe Pfizer Bavencio Novartis Rydapt Lexicon Pharmaceuticals Xermelo Vanda Fanaptum Nektar Onzeald Daiichi Sankyo
3 Small-Cap Biotechs That Institutions Are Loving Submitted by admin on Mon, 07/07/2014 - 19:30 Read more about 3 Small-Cap Biotechs That Institutions Are Loving Source Yahoo/Benzinga Headline 3 Small-Cap Biotechs That Institutions Are Loving News Tags Infinity Pharmaceuticals Vanda Lexicon Pharmaceuticals
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology Submitted by admin on Tue, 06/03/2014 - 11:38 Read more about Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology Source Motley Fool Headline Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Onco… News Tags Vanda Prosensa Clovis Oncology Hetlioz CO-1686 drisapersen
Vanda Pharmaceuticals Wins FDA Approval of Sleep Disorder Drug Submitted by admin on Sat, 02/01/2014 - 10:44 Read more about Vanda Pharmaceuticals Wins FDA Approval of Sleep Disorder Drug Source Wall St Cheat Sheet Headline Vanda Pharmaceuticals Wins FDA Approval of Sleep Disorder Drug News Tags Hetlioz Vanda sleep aid hypnotics
Will the FDA Approve Vanda's Hetlioz? Submitted by admin on Tue, 01/28/2014 - 11:54 Read more about Will the FDA Approve Vanda's Hetlioz? Source Motley Fool Headline Will the FDA Approve Vanda's Hetlioz? News Tags Vanda FDA Hetlioz non-24 hour disorder
2014 Biotechnology Catalysts Submitted by admin on Fri, 01/10/2014 - 08:14 Read more about 2014 Biotechnology Catalysts Source Seeking Alpha Headline 2014 Biotechnology Catalysts News Tags Chelsea Therapeutics Durect Corporation EXACT Sciences Vanda Pozen Progenics MannKind FDA
22 Biotech Stock Predictions for 2014 Submitted by admin on Mon, 01/06/2014 - 09:47 Read more about 22 Biotech Stock Predictions for 2014 Source TheStreet.com Headline 22 Biotech Stock Predictions for 2014 News Tags biotech Vertex Pharmaceuticals Orexigen Retrophin Valeant Pharmaceuticals Questcor Biomarin Merck NeoStem Amgen Gilead Sciences Vanda Keryx Peregrine Pharmaceuticals CelSci Regeneron Cempra Dendreon Clovis Oncology Halozyme NPS Pharmaceuticals
2014 FDA Drug Approval Decision Calendar Submitted by admin on Wed, 11/27/2013 - 08:39 Read more about 2014 FDA Drug Approval Decision Calendar Source TheStreet.com Headline 2014 FDA Drug Approval Decision Calendar News Tags FDA drug approvals GSK Gilead Theravance Auxilium Amarin Bristol-Myers Squibb Biogen Idec Pozen Vanda Chelsea Therapeutics pSivida Alimera United Therapeutics Biomarin JNJ Pharmacyclics Celgene MannKind Santarus AstraZeneca Durata Therapeutics Eli Lilly Omeros BioDelivery Sciences Anacor Keryx Cubist Pharmaceuticals Nektar
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps Submitted by admin on Wed, 11/20/2013 - 11:47 Read more about Biotech Stock Roundup: Vanda Soars, Sarepta Slumps Source Yahoo/Zacks.com Headline Biotech Stock Roundup: Vanda Soars, Sarepta Slumps News Tags Vanda Sarepta Therapeutics tasimelteon Hetlioz Duchenne Muscular Dystrophy eteplirsen
Amarin, Sarepta And Vanda: Teachable Moments In Biotech Submitted by admin on Sun, 11/17/2013 - 12:13 Read more about Amarin, Sarepta And Vanda: Teachable Moments In Biotech Source Seeking Alpha Headline Amarin, Sarepta And Vanda: Teachable Moments In Biotech News Tags Amarin Sarepta Vanda